Liquidia Technologies Inc (LQDA)
$42.28
$0.14
(0.33%)
As on 07-May-2026 16:00EDT
Market cap
$3,746 Mln
Revenue (TTM)
$158 Mln
P/E Ratio
--
P/B Ratio
76.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-9.4
-
Debt to Equity
4.4
-
Book Value
$0.5
-
EPS
$-0.8
-
Face value
--
-
Shares outstanding
88,893,621
8 Years Aggregate
CFO
$-276.68 Mln
EBITDA
$-323.08 Mln
Net Profit
$-348.75 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Liquidia Technologies Inc (LQDA)
| 22.6 | 12.3 | 1.7 | 172.2 | 78.8 | 75.4 | -- |
|
BSE Sensex*
| -8.6 | 3.7 | -7.4 | -4.1 | 8.2 | 9.5 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Liquidia Technologies Inc (LQDA)
| 193.3 | -2.2 | 88.9 | 30.8 | 65.1 | -31.0 | -80.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Liquidia Technologies Inc (LQDA)
|
42.3 | 3,746.0 | 158.3 | -68.9 | -29.3 | -113 | -- | 76.5 |
| 13.7 | 4,344.8 | 2,323.3 | 137.9 | 12.3 | -- | 61.9 | 105.4 | |
| 41.0 | 5,264.2 | 1,003.8 | 22.4 | 6.8 | 7.5 | 228.4 | 14.2 | |
| 220.2 | 11,456.5 | 638.5 | -183.2 | -27.4 | -252.1 | -- | 210.8 | |
| 67.5 | 13,200.1 | 502.1 | -729.3 | -125.8 | 41.2 | -- | 123.7 | |
| 31.2 | 3,734.0 | 589.0 | 214.3 | 46.8 | 25.5 | 18.2 | 3.7 | |
| 51.1 | 5,598.4 | 769.1 | 47.9 | 5.4 | 7.5 | 149 | 8.6 | |
| 24.0 | 13,073.8 | 4,715.0 | -232.0 | 0.9 | -3.7 | -- | 1.7 | |
| 8.1 | 5,723.6 | 7,682.7 | 438.7 | 15.9 | 7.5 | 12.2 | 0.9 | |
| 58.5 | 3,707.0 | 391.6 | -76.6 | -19.3 | -16.4 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Liquidia Technologies Inc (LQDA)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder... formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. Address: 419 Davis Drive, Morrisville, NC, United States, 27560 Read more
-
CEO & Director
Dr. Roger A. Jeffs Ph.D.
-
CEO & Director
Dr. Roger A. Jeffs Ph.D.
-
Headquarters
Morrisville, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Liquidia Technologies Inc (LQDA)
What is the current share price of Liquidia Technologies Inc (LQDA) Today?
The share price of Liquidia Technologies Inc (LQDA) is $42.28 (NASDAQ) as of 07-May-2026 16:00 EDT. Liquidia Technologies Inc (LQDA) has given a return of 78.77% in the last 3 years.
What is the current PB & PE ratio of Liquidia Technologies Inc (LQDA)?
Since, TTM earnings of Liquidia Technologies Inc (LQDA) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-43.03
|
66.29
|
|
2024
|
-7.12
|
12.02
|
|
2023
|
-9.96
|
16.53
|
|
2022
|
-9.47
|
4.30
|
|
2021
|
-7.04
|
3.73
|
What is the 52 Week High and Low of Liquidia Technologies Inc (LQDA)?
The 52-week high and low of Liquidia Technologies Inc (LQDA) are Rs 46.67 and Rs 11.85 as of 08-May-2026.
What is the market cap of Liquidia Technologies Inc (LQDA)?
Liquidia Technologies Inc (LQDA) has a market capitalisation of $ 3,746 Mln as on 07-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Liquidia Technologies Inc (LQDA)?
Before investing in Liquidia Technologies Inc (LQDA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.